352 related articles for article (PubMed ID: 15145458)
1. Anti-complement effects of lactoferrin-derived peptides.
Samuelsen Ø; Haukland HH; Ulvatne H; Vorland LH
FEMS Immunol Med Microbiol; 2004 Jun; 41(2):141-8. PubMed ID: 15145458
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
Kievits F; Kijlstra A
Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
[TBL] [Abstract][Full Text] [Related]
3. Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling.
Farnaud S; Patel A; Odell EW; Evans RW
FEMS Microbiol Lett; 2004 Sep; 238(1):221-6. PubMed ID: 15336425
[TBL] [Abstract][Full Text] [Related]
4. Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity.
Farnaud S; Spiller C; Moriarty LC; Patel A; Gant V; Odell EW; Evans RW
FEMS Microbiol Lett; 2004 Apr; 233(2):193-9. PubMed ID: 15063486
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin.
Hwang PM; Zhou N; Shan X; Arrowsmith CH; Vogel HJ
Biochemistry; 1998 Mar; 37(12):4288-98. PubMed ID: 9521752
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum.
Walpen AJ; Laumonier T; Aebi C; Mohacsi PJ; Rieben R
Xenotransplantation; 2004 Mar; 11(2):141-8. PubMed ID: 14962276
[TBL] [Abstract][Full Text] [Related]
7. Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides.
Liu Y; Han F; Xie Y; Wang Y
Biometals; 2011 Dec; 24(6):1069-78. PubMed ID: 21607695
[TBL] [Abstract][Full Text] [Related]
8. Homology similarity analysis of sequences of lactoferricin and its derivatives.
Nakai S; Chan JC; Li-Chan EC; Dou J; Ogawa M
J Agric Food Chem; 2003 Feb; 51(5):1215-23. PubMed ID: 12590458
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of a 2-arylsulphonylated tryptophan: the antibacterial activity of bovine lactoferricin peptides containing Trp(2-Pmc).
Haug BE; Andersen J; Rekdal O; Svendsen JS
J Pept Sci; 2002 Jul; 8(7):307-13. PubMed ID: 12148780
[TBL] [Abstract][Full Text] [Related]
10. Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin.
van der Kraan MI; Groenink J; Nazmi K; Veerman EC; Bolscher JG; Nieuw Amerongen AV
Peptides; 2004 Feb; 25(2):177-83. PubMed ID: 15062998
[TBL] [Abstract][Full Text] [Related]
11. Contribution of bovine lactoferrin inter-lobe region to iron binding stability and antimicrobial activity against Staphylococcus aureus.
Bai X; Teng D; Tian Z; Zhu Y; Yang Y; Wang J
Biometals; 2010 Jun; 23(3):431-9. PubMed ID: 20145976
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the wine spoilage yeast Dekkera bruxellensis by bovine lactoferrin-derived peptides.
Enrique M; Marcos JF; Yuste M; Martínez M; Vallés S; Manzanares P
Int J Food Microbiol; 2008 Oct; 127(3):229-34. PubMed ID: 18706729
[TBL] [Abstract][Full Text] [Related]
13. Selectivity and antimicrobial action of bovine lactoferrin derived peptides against wine lactic acid bacteria.
Enrique M; Manzanares P; Yuste M; Martínez M; Vallés S; Marcos JF
Food Microbiol; 2009 May; 26(3):340-6. PubMed ID: 19269579
[TBL] [Abstract][Full Text] [Related]
14. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans.
Chen HL; Yen CC; Lu CY; Yu CH; Chen CM
J Agric Food Chem; 2006 May; 54(9):3277-82. PubMed ID: 16637685
[TBL] [Abstract][Full Text] [Related]
15. High dose intravenous immunoglobulin does not affect complement-bacteria interactions.
Wagner E; Platt JL; Frank MM
J Immunol; 1998 Feb; 160(4):1936-43. PubMed ID: 9469456
[TBL] [Abstract][Full Text] [Related]
16. Peptides from the N-terminal end of bovine lactoferrin induce apoptosis in human leukemic (HL-60) cells.
Roy MK; Kuwabara Y; Hara K; Watanabe Y; Tamai Y
J Dairy Sci; 2002 Sep; 85(9):2065-74. PubMed ID: 12362437
[TBL] [Abstract][Full Text] [Related]
17. Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis.
Ulvatne H; Samuelsen Ø; Haukland HH; Krämer M; Vorland LH
FEMS Microbiol Lett; 2004 Aug; 237(2):377-84. PubMed ID: 15321686
[TBL] [Abstract][Full Text] [Related]
18. Simple parameterization of non-proteinogenic amino acids for QSAR of antibacterial peptides.
Lejon T; Svendsen JS; Haug BE
J Pept Sci; 2002 Jul; 8(7):302-6. PubMed ID: 12148779
[TBL] [Abstract][Full Text] [Related]
19. Activation of the classical pathway of complement by binding of bovine lactoferrin to unencapsulated Streptococcus agalactiae.
Rainard P
Immunology; 1993 Aug; 79(4):648-52. PubMed ID: 8406591
[TBL] [Abstract][Full Text] [Related]
20. Expression of the cationic antimicrobial peptide lactoferricin fused with the anionic peptide in Escherichia coli.
Kim HK; Chun DS; Kim JS; Yun CH; Lee JH; Hong SK; Kang DK
Appl Microbiol Biotechnol; 2006 Sep; 72(2):330-8. PubMed ID: 16421719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
